Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.

Axon Therapies developed the SAVM procedure. Their novel approach to modulating the body’s sympathetic nervous system to restore balance in the circulatory system.

Institut de Recherches Cliniques de Montr?al operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada.

CardioMEMS LLC designs and manufactures wireless sensing and communication technology for the human body. Its technology platform is designed to improve the management of severe chronic cardiovascular diseases, such as heart failure and aneurysms. The firm’s miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients. The company was founded by Mark G. Allen and Jay S. Yadav in 1999 is headquartered in Atlanta, GA.

Manufactures pharmaceutical products

Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinical and clinical candidates including the company's lead compound, CXL-1020, currently in clinical development for Acute Decompensated Heart Failure, the most common cause of hospitalization for patients older than 65 years of age.

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. They have four approved products on the market today and they are not stopping there! From the United States to Europe to the Asia Pacific, they are proud of their multicultural business environment where employees can collaborate with people all over the world. As a group, they are relentless in their pursuit of “medicines for life”® and continue their research into treatments for pulmonary arterial hypertension, cancer, and some of the world’s most complicated viral illnesses.

The company provides digital health software and hardware intended to offer proprietary insights into the pulmonary vasculature non-invasively and the product pipeline aims to address both at-home monitoring and critical care applications in categories such as heart failure and hemodynamics.

Fu Wai Hospital, founded in 1956.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Gmax Biopharm LLC is a Chinese company located in Hangzhou that operates as an antibody development platform. It was founded by Shuqian Jing and Richard Xu. Shuqian Jing is currently the CEO of the firm.\nThe company says this about itself: Gmax is a clinical stage company established in 2010 and headquartered in Hangzhou, China. It's a global company focusing on R&D, production and commercialization of antibody drugs targeting GPCRs. Gmax mainly works in cardiovascular, metabolic and cancer areas. Currently there are four drug development programs in different stages of clinical trials: GMA 102 (type 2 diabetes), GMA105 (obesity), GMA301A (PAH for adult), and GMA 301B (PAH for children).

Shanghai Haofeng Pharmaceutical Technology Co., Ltd., established on 2016-06-20, The scope of business includes engaging in technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer,laboratory equipment,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,public opinion explosives,precursor chemicals),Sales of Class I Medical Devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

HemoCath-guided healthcare for patients with heart failure has the potential to improve clinical outcomes and reduce hospital length of stay. HemoCath Ltd. is an early-stage Canadian/US/Irish company that has developed and is now commercializing outside the United States the HemoCath Pulmonary Artery (PA) Catheter, indicated for the assessment of a patient’s hemodynamic condition through direct simultaneous central venous pressure (CVP) and pulmonary artery pressure (PAP) monitoring. HemoCath PA Catheter is less invasive due to its 4F catheter size and easier-to-use by design.

TC1 LLC, part of Abbott Laboratories, is a company headquartered in the United States that manufactures blood pressure apparatus.

Nanjing Shengdaoyuan Pharmaceutical Technology Co., Ltd., established on 2014-08-21, Business scope includes bioengineering technology development,technical consulting,technology transfer;Computer software and hardware technology development,transfer,consultation service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Pharmacia & Upjohn AB is a private company headquartered in Stockholm, Sweden. The firm manufactures pharmaceutical drugs.